This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study of Nivolumab in Subjects With Relapsed or Re...
Clinical trial

Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)

Read time: 1 mins
Last updated:15th Jan 2014

The purpose of this study is to assess the clinical benefit of Nivolumab, as measured by independent radiologic review committee (IRRC)-assessed objective response rate (ORR) in subjects with Follicular Lymphoma (FL) who have failed therapy with both Rituximab and an Alkylating agent.

Category Value
Study start date 2014-01-15

View full details